new and historical books in bioscience and medicine
FDA released a report addressing the recent slowdown in innovative medical therapies submitted to the FDA for approval, "Innovation/Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products." The report describes the urgent need to modernize the medical product development process -- the Critical Path -- to make product development more predictable and less costly.